WINREVAIR subst sèche 45 mg c solv flac
7680697870013
CH-69787
C02KX
02.07.1.
Reimbursement limitations:
WINREVAIR.01
WINREVAIR est remboursé pour le traitement de l'hypertension artérielle pulmonaire (HTAP) des classes fonctionnelles II …
1 / 3
google
Details
- Product number
- 6978701
- CPT
- -
- Packaging group
- 1
- Unit
- Set
- Composition
- Praeparatio cryodesiccata: sotaterceptum 45 mg, acidum citricum, trinatrii citras dihydricus corresp. natrium 0.49 mg, polysorbatum 80, saccharum, pro vitro. Solvens: aqua ad iniectabile q.s. ad solutionem pro.
Articles (1)
Winrevair 45 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLV
|
- | Substance | HNIDK |
|
PRC
|
45.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
0.49 MG | Substance | HBESI |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 6419.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2024
Authorization holder
MSD Merck Sharp & Dohme AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 69787
- Drug name
- Winrevair, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
- Galenic form
- PULMJ
- ATC Code
- C02KX
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 16/10/2024
- Authorization expiration date
- 15/10/2029
- IT number
- 02.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- WINREVAIR subst seche 45 mg 1 pce
- Description (DE)
- WINREVAIR Trockensub 45 mg 1 Stk
- Market launch
- 16/10/2024
- Narcotic (BTM)
- No